Edition:
India

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (0874.HK)

0874.HK on Hong Kong Stock

37.20HKD
23 May 2018
Change (% chg)

HK$0.95 (+2.62%)
Prev Close
HK$36.25
Open
HK$36.40
Day's High
HK$38.35
Day's Low
HK$36.40
Volume
4,982,040
Avg. Vol
3,111,541
52-wk High
HK$38.35
52-wk Low
HK$19.00

Latest Key Developments (Source: Significant Developments)

Guangzhou Baiyunshan Pharmaceutical Holdings Co Says Qtrly Net Profit Attributable RMB905.2 Mln
Thursday, 26 Apr 2018 

April 26 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::QTRLY INCOME FROM OPERATIONS RMB 6.91 BILLION VERSUS RMB5.29 BILLION.QTRLY NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS RMB905.2 MILLION VERSUS RMB484.7 MILLION.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings to pay cash dividend of 3.81 yuan (pre-tax) for every 10 shares
Friday, 16 Mar 2018 

March 16 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says it plans to pay a cash dividend of 3.81 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017 .  Full Article

Guangzhou Baiyunshan Pharma's 2017 Net Profit Up 36.7 Percent Y/Y
Thursday, 15 Mar 2018 

March 15 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS 2017 NET PROFIT UP 36.7 PERCENT Y/Y.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Monday, 12 Mar 2018 

March 12(Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says co's unit Guangzhou Baiyunshan Xingqun Pharmaceutical Co Ltd received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration.Says valid period is until Feb. 28, 2023.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings branch receives GMP certificate
Thursday, 1 Mar 2018 

March 1 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS> ::Says its branch received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration.Certificate issued oculentum manufactured by the branch and the valid period is until Jan. 14, 2023.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Tuesday, 27 Feb 2018 

Feb 27(Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says co's Guangzhou-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration recently.Says valid period is until Feb. 10, 2023.  Full Article

Guangzhou Baiyunshan Pharma To Invest 800 Mln Yuan Each In Two Health Industry Funds
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS IT PLANS TO SET UP TWO INVESTMENT JVS AND TO INVEST UP TO 800 MILLION YUAN ($126.19 million) EACH IN TWO HEALTH INDUSTRY FUNDS.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says Guangzhou-based pharmacy unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration .Certificate issued to oral dosage, Cephalospora capsule, sirup, granules and tablet manufactured by the unit and the valid period is until Dec. 19, 2022.  Full Article

Guangzhou Baiyunshan Pharmaceutical To Acquire Stake In Guangzhou Pharma
Friday, 22 Dec 2017 

Dec 22 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS IT PLANS TO ACQUIRE 30 PERCENT STAKE IN GUANGZHOU PHARMA FOR 1.09 BILLION YUAN ($165.84 million).SAYS TO OWN 80 PERCENT STAKE OF GUANGZHOU PHARMA AFTER THE TRANSACTION.SAYS SELLER HAS THE OPTION TO SELL THE REMAINING 20 PERCENT STAKE IN GUANGZHOU PHARMA.  Full Article

Guangzhou Baiyunshan Pharmaceutical Updates On Suspension Of Trading Of A Shares
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::REFERS TO ANNOUNCEMENT OF COMPANY DATED 30 OCTOBER IN RELATION TO SUSPENSION OF TRADING OF A SHARES.‍AS AT 4 DEC, PROPOSED ACQUISITION IS IN PROGRESS​.GIVEN UNCERTAINTY REGARDING PROPOSED PURCHASE, CO'S A SHARES TO CONTINUE TO BE SUSPENDED.  Full Article